These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25614169)

  • 21. Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease.
    Huiberts A; Zweijpfenning SMH; Pennings LJ; Boeree MJ; van Ingen J; Magis-Escurra C; Hoefsloot W
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31000680
    [No Abstract]   [Full Text] [Related]  

  • 22. Cefoxitin continuous infusion for lung infection caused by the Mycobacterium abscessus group.
    Czaja CA; Levin A; Moridani M; Krank JL; Curran-Everett D; Anderson PL
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3570-1. PubMed ID: 24733469
    [No Abstract]   [Full Text] [Related]  

  • 23. Skin disease and nontuberculous atypical mycobacteria.
    Palenque E
    Int J Dermatol; 2000 Sep; 39(9):659-66. PubMed ID: 11044189
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvant surgical treatment of nontuberculous mycobacterial lung disease.
    Shiraishi Y; Katsuragi N; Kita H; Hyogotani A; Saito MH; Shimoda K
    Ann Thorac Surg; 2013 Jul; 96(1):287-91. PubMed ID: 23618520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of alcohol consumption in the treatment of nontuberculous mycobacteria.
    Jacob M; Silva R; Gaio R; Duarte R
    Pulmonology; 2020; 26(4):249-252. PubMed ID: 31672591
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nontuberculous mycobacteria].
    Emmerich K; Fabri M
    Hautarzt; 2017 May; 68(5):403-411. PubMed ID: 28331949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to 2014.
    El-Zeenni N; Chanoine S; Recule C; Stahl JP; Maurin M; Camara B
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):233-240. PubMed ID: 29067624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
    Zwoliński J; Gałazka J
    Pneumonol Alergol Pol; 1992; 60(5-6):70-3. PubMed ID: 1290992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
    PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
    Somoskovi A; Salfinger M
    Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.
    Pigem R; Cairó M; Martínez-Lacasa X; Irigoyen D; Miró JM; Acevedo J; Fernández J; Alsina-Gibert M
    J Am Acad Dermatol; 2013 Oct; 69(4):e192-3. PubMed ID: 24034397
    [No Abstract]   [Full Text] [Related]  

  • 34. Infection by Mycobacterium szulgai in a patient with pulmonary tuberculosis.
    Olmos JM; Peralta FG; Mellado A; González-Macías J
    Eur J Clin Microbiol Infect Dis; 1994 Aug; 13(8):689-90. PubMed ID: 7813507
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of oral minocycline and hyperthermic treatment in a case of atypical mycobacterial skin infection by Mycobacterium marinum.
    Hisamichi K; Hiruma M; Yamazaki M; Matsushita A; Ogawa H
    J Dermatol; 2002 Dec; 29(12):810-1. PubMed ID: 12532049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated Mycobacterium abscessus infection and showerheads, Taiwan.
    Kuo YM; Cheng A; Wu PC; Hsieh SC; Hsieh SM; Hsueh PR; Yu CL
    Emerg Infect Dis; 2011 Nov; 17(11):2077-8. PubMed ID: 22099106
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.
    Coolen-Allou N; Touron T; Belmonte O; Gazaille V; Andre M; Allyn J; Picot S; Payet A; Veziris N
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760130
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
    Philley JV; Griffith DE
    Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non Tuberculous Mycobacteria--a Short Review about Epidemiology, Diagnosis and Treatment].
    Bös L; Schönfeld N; Schaberg T
    Pneumologie; 2015 May; 69(5):287-93; quiz 294. PubMed ID: 25970123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.